We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+10.15%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$132M
AUM Growth
-$14.8M
(-10%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
54.12%
Holding
159
New
33
Increased
15
Reduced
30
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Broadband Class C
LBRDK
|
+$3.61M |
| 2 |
SI
Silvergate Capital Corporation
SI
|
+$3.17M |
| 3 |
ACIA
Acacia Communications Inc
ACIA
|
+$2.94M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$2.01M |
| 5 |
Alibaba
BABA
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$4.52M |
| 2 |
Fox Class B
FOX
|
+$3.9M |
| 3 |
RP
RealPage, Inc.
RP
|
+$3.8M |
| 4 |
CELG
Celgene Corp
CELG
|
+$3.65M |
| 5 |
AGN
Allergan plc
AGN
|
+$3.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.19% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Healthcare | 14.13% |
| 4 | Communication Services | 6.47% |
| 5 | Financials | 4.34% |
Similar funds
SIAG
MS
WI
BHBT
WTFG
RC
VIA
A6
HighVista Strategies's Q4 2019 Portfolio in Review
As of Q4 2019, HighVista Strategies held 159 positions worth $132M, down 10% from $147M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
HighVista Strategies withdrew a net $22.6M in Q4 2019, closing 40 positions and reducing 30 holdings. Its most notable exit was Medicines Co, an estimated $4.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, HighVista Strategies opened a new position in Liberty Broadband Class C worth $3.9M.
- HighVista Strategies's largest Q4 2019 buy was Liberty Broadband Class C: 31,000 shares worth $3.9M.
- HighVista Strategies added most to Alibaba in Q4 2019, an estimated $1.5M increase.
- HighVista Strategies's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $3.33M.
- HighVista Strategies fully exited Medicines Co in Q4 2019, selling an estimated $4.52M.
- HighVista Strategies's ten largest holdings make up 54% of its $132M portfolio in Q4 2019.
- HighVista Strategies opened 33 new positions and closed 40 in Q4 2019.
- HighVista Strategies's portfolio value fell 10% quarter-over-quarter to $132M.
Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.